-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Praxis Precision Medicine, Raises Price Target to $507

Benzinga·12/08/2025 10:41:14
Listen to the news
BTIG analyst Kambiz Yazdi maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $499 to $507.